St. Jude's (STJ) warning about battery risks in its implanted heart devices are big but will likely not disrupt its deal with Abbott Labs (ABT) , said TheStreet's Jim Cramer. Shares of St. Jude Medical are down Tuesday after the medical device maker warned patients that batteries in its implanted heart devices could deplete prematurely. "There have been two deaths that have been associated with the loss of defibrillation therapy as a result of premature battery depletion," St. Jude VP of Quality Control Jeff Fecho said in the letter to physicians.
More from Video
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.